6676 - 6700 of 8436 Results
Title
Year
- Call to Caution with the Use of Atypical Antipsychotics for Treatment of Depression in Older Adults2016OPENTitle: Call to Caution with the Use of Atypical Antipsychotics for Treatment of Depression in Older AdultsJournal Name: GeriatricsPublisher: MDPI AGVol: 1Issue #: 4Start Page: 33End Page: 33Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/geriatrics1040033Best OA location URL: https://www.mdpi.com/2308-3417/1/4/33/pdf?version=1481882897Citation Count: 2
-
RESTRICTEDTitle: The clinical heterogeneity of drug-induced myoclonus: an illustrated reviewJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 264Issue #: 8Start Page: 1559End Page: 1566Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-016-8357-zBest OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs00415-016-8357-z.pdfCitation Count: 31
- A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s Disease2016OPENTitle: A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s DiseaseJournal Name: Cell SystemsPublisher: Elsevier BVVol: 4Issue #: 1Start Page: 60End Page: 72.e4Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cels.2016.11.006Citation Count: 446
-
OPENTitle: Heritability of the shape of subcortical brain structures in the general populationJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/ncomms13738Best OA location URL: https://www.nature.com/articles/ncomms13738.pdfCitation Count: 97
-
OPENTitle: Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic NeurotransmissionJournal Name: CNS Neuroscience & TherapeuticsPublisher: WileyVol: 23Issue #: 2Start Page: 162End Page: 173Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/cns.12660Best OA location URL: https://doi.org/10.1111/cns.12660Citation Count: 28
- Frontotemporal dementia as the presenting phenotype of p.A53T mutation carriers in the alpha-synuclein gene2016RESTRICTEDTitle: Frontotemporal dementia as the presenting phenotype of p.A53T mutation carriers in the alpha-synuclein geneJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 35Issue #:Start Page: 82End Page: 87Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.12.002Citation Count: 28
- Use, maintenance and dose effects of cognitive speed of processing training in Parkinson's disease2016OPENTitle: Use, maintenance and dose effects of cognitive speed of processing training in Parkinson's diseaseJournal Name: International Journal of NeurosciencePublisher: Informa UK LimitedVol: 127Issue #: 10Start Page: 841End Page: 848Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/00207454.2016.1269088Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284743Citation Count: 9
- Current status of the development of PET radiotracers for imaging alpha synuclein aggregates in Lewy bodies and Lewy neurites2016RESTRICTEDTitle: Current status of the development of PET radiotracers for imaging alpha synuclein aggregates in Lewy bodies and Lewy neuritesJournal Name: Clinical and Translational ImagingPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 3End Page: 14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40336-016-0217-4Citation Count: 46
- Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation2016RESTRICTEDTitle: Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulationJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 2Start Page: 274End Page: 277Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26882Citation Count: 29
- LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies2016RESTRICTEDTitle: LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodiesJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 3Start Page: 423End Page: 432Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26892Citation Count: 42
- Patient Perspectives on Deep Brain Stimulation Clinical Research in Early Stage Parkinson’s Disease2016RESTRICTEDTitle: Patient Perspectives on Deep Brain Stimulation Clinical Research in Early Stage Parkinson’s DiseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 7Issue #: 1Start Page: 89End Page: 94Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-161031Citation Count: 13
-
OPENTitle: Imaging analysis of Parkinson’s disease patients using SPECT and tractographyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep38070Best OA location URL: https://www.nature.com/articles/srep38070.pdfCitation Count: 35
- Interview with Mark Frasier: A Michael J Fox Foundation Perspective on Precision Medicine in Parkinson’S2016OPENTitle: Interview with Mark Frasier: A Michael J Fox Foundation Perspective on Precision Medicine in Parkinson’SJournal Name: Personalized MedicinePublisher: Informa UK LimitedVol: 14Issue #: 1Start Page: 13End Page: 15Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/pme-2016-0087Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/pme-2016-0087Citation Count: 0
-
OPENTitle: Fbxl18 targets LRRK2 for proteasomal degradation and attenuates cell toxicityJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 98Issue #:Start Page: 122End Page: 136Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2016.11.004Best OA location URL: https://europepmc.org/articles/pmc5718210?pdf=renderCitation Count: 13
- Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences2016RESTRICTEDTitle: Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciencesJournal Name: Briefings in BioinformaticsPublisher: Oxford University Press (OUP)Vol: 19Issue #: 2Start Page: 286End Page: 302Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/bib/bbw114Best OA location URL: https://academic.oup.com/bib/article-pdf/19/2/286/25524262/bbw114.pdfCitation Count: 515
- Proceedings of the Fourth Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies2016RESTRICTEDTitle: Proceedings of the Fourth Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and TechnologiesJournal Name: Frontiers in Integrative NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnint.2016.00038Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnint.2016.00038/pdfCitation Count: 50
- Cerebral Amyloid Deposition Is Associated with Gait Parameters in the Mayo Clinic Study of Aging2016OPENTitle: Cerebral Amyloid Deposition Is Associated with Gait Parameters in the Mayo Clinic Study of AgingJournal Name: Journal of the American Geriatrics SocietyPublisher: WileyVol: 65Issue #: 4Start Page: 792End Page: 799Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jgs.14670Best OA location URL: https://europepmc.org/articles/pmc5397339?pdf=renderCitation Count: 53
- Structural cerebellar correlates of cognitive and motor dysfunctions in cerebellar degeneration2016OPENTitle: Structural cerebellar correlates of cognitive and motor dysfunctions in cerebellar degenerationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page: aww327End Page: aww327Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/aww327Best OA location URL: https://academic.oup.com/brain/article-pdf/140/3/707/24174786/aww327.pdfCitation Count: 111
- Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study2016OPENTitle: Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 16Issue #: 1Start Page: 66End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(16)30328-3Best OA location URL: http://doi.org/10.1016/S1474-4422(16)30328-3Citation Count: 363
- Cognitive phenotypes in parkinson's disease differ in terms of brain‐network organization and connectivity2016OPENTitle: Cognitive phenotypes in parkinson's disease differ in terms of brain‐network organization and connectivityJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 3Start Page: 1604End Page: 1621Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23474Best OA location URL: https://europepmc.org/articles/pmc6867173?pdf=renderCitation Count: 87
- Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PREDIGT score2016OPENTitle: Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PREDIGT scoreJournal Name: European Journal of NeurosciencePublisher: WileyVol: 45Issue #: 1Start Page: 175End Page: 191Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ejn.13476Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.13476Citation Count: 24
- Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson’s Disease2016OPENTitle: Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2016.00271Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2016.00271/pdfCitation Count: 6
- Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 Mutations2016OPENTitle: Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 MutationsJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 11Start Page: e0166053End Page: e0166053Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0166053Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0166053&type=printableCitation Count: 17
-
OPENTitle: Bifunctional Anti-Non-Amyloid Component α-Synuclein Nanobodies Are Protective In SituJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 11Start Page: e0165964End Page: e0165964Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0165964Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0165964&type=printableCitation Count: 61
-
RESTRICTEDTitle: Cerium oxide nanoparticles in neuroprotection and considerations for efficacy and safetyJournal Name: WIREs Nanomedicine and NanobiotechnologyPublisher: WileyVol: 9Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/wnan.1444Best OA location URL: https://europepmc.org/articles/pmc5422143?pdf=renderCitation Count: 110